Lupin Limited has informed the Exchange about press release dated 30-Jun-2022 titled Lupin Receives Approval from U.S. FDA for Paliperidone Extended-Release Tablets.
Lupin Limited has informed the Exchange about press release dated 30-Jun-2022 titled Lupin Receives Approval from U.S. FDA for Paliperidone Extended-Release Tablets.